🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To learn if adding a healthy person's natural killer (NK) cells to the comb...
Status
Recruiting
Location
Case Western Reserve University
Start Date
2023-10-26
Trial ID
NCT05834244
Treatments Being Tested
This is an open label, Phase 1/2, first-in-human, multiple ascending dose, ...
Status
Recruiting
Location
Valkyrie Clinical Trials
Start Date
2023-10-25
Trial ID
NCT06119685
Treatments Being Tested
Combinations Natural Killer Cell (NK) With chemotherapy treatment may enhan...
Status
Unknown
Location
Yantai Yuhuangding Hospital
Start Date
2019-12-31
Trial ID
NCT04214730
Treatments Being Tested
To find the highest and/or recommended dose of TROP2-CAR-NK cells combined ...
Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-12-02
Trial ID
NCT06358430
This phase 2 clinical trial investigates the effectiveness of cytokine-indu...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06-30
Trial ID
NCT04354025
Treatments Being Tested
The purpose of this study is to assess the safety profile of brentuximab ve...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2011-02
Trial ID
NCT01309789
This Phase 2a trial will evaluate the safety and efficacy of NK cell therap...
Status
Completed
Location
Seon-Ah Ha
Start Date
2019-10-15
Trial ID
NCT05040438
Treatments Being Tested
This phase I trial is to find out the best dose, possible benefits and/or s...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2022-05-06
Trial ID
NCT04848064
This is an open label, Phase 1b, multiple ascending dose, and dose-expansio...
Status
Suspended
Location
Stanford University
Start Date
2026-06-30
Trial ID
NCT06677710
Treatments Being Tested
To evaluate the efficacy and safety of first-line gemcitabine, oxaliplatin,...
Status
Unknown
Location
Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China,
Start Date
2014-03
Trial ID
NCT02080234